Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ivax appoints new head; Debregeas and Le Portz get on board

This article was originally published in Clinica

Executive Summary

Miami, Florida-based IVAX Diagnostics has appointed pharmaceutical industry veteran Paul Kennedy as CEO, president and chairman. Mr Kennedy has held senior executive positions at Novo Nordisk France, Abbot France and UK health retailer Boots. He was most recently at Cozart, the UK drugs-of-abuse testing company that was bought by Concateno in October 2007, where he established and grew the company's international sales. In conjunction with Mr Kennedy's appointment, IVAX announced that Patrice Debregeas – one of the two entrepreneurs that bought a major stake in IVAX last month (see Clinica No 1323, p 18) -- is to become vice-chairman. Seasoned healthcare investor Laurent Le Portz will also join the board of directors and IVAX's audit and compensation committees.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042612

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel